Paying attention to your bodys hunger and fullness cues can help prevent overeating and minimize side effects
Hormone Replacement Therapy : Balance hormones for optimal health
GLP-1 receptor agonists are not recommended for use in patients with severe gastrointestinal disease, including gastroparesis
By combining high-quality supplementation with a mindful lifestyle, you can build a wellness routine that feels empowering and effective
STUDY CONCLUSIONS In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide titrated up to a dose of 2.4 mg was superior to placebo in reducing the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke at a mean follow-up of 40 months
Future Research Directions Future research should focus on identifying which patients have clinically meaningful retained gastric contents and which mitigation strategies reduce risk without causing unnecessary cancellations or metabolic harm